BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lugoboni F, Mirijello A, Morbioli L, Faccini M, Casari R, De Cosmo S, Gasbarrini A, Addolorato G. Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients. Expert Opinion on Drug Safety 2019;18:753-8. [DOI: 10.1080/14740338.2019.1628216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Lugoboni F, Casari R, Fusina F, Zamboni L. Zolpidem: A masked hero. A reply to ZORRO study. Br J Clin Pharmacol 2021. [PMID: 33763898 DOI: 10.1111/bcp.14820] [Reference Citation Analysis]
2 Casari R, Zamboni L, Fusina F, Lugoboni F. Letter to editor, a comment to: Prevalence and concentrations of sedative-hypnotic drugs in blood of drivers involved in road traffic crashes in the Padova region of Italy − Not so easy to interpret. Forensic Science International 2022;332:111204. [DOI: 10.1016/j.forsciint.2022.111204] [Reference Citation Analysis]
3 Orsolini L, Chiappini S, Grandinetti P, Bruschi A, Testa R, Provenzano A, Berardis D, Volpe U. 'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse. Clin Psychopharmacol Neurosci 2021;19:367-87. [PMID: 33888666 DOI: 10.9758/cpn.2021.19.2.367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Horowski R. Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures. J Neural Transm 2020;127:1107-15. [DOI: 10.1007/s00702-020-02209-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mansueto G, Lugoboni F, Casari R, Bertoldi A, Cosci F. Mono- and poly-therapy with benzodiazepines or Z-drugs: Results from a tertiary-care Addiction Unit study. Int J Risk Saf Med 2021. [PMID: 34120917 DOI: 10.3233/JRS-210014] [Reference Citation Analysis]